SOVREMENNAYA PEDIATRIYA.2016.4(76):67-73; doi10.15574/SP.2015.72.67 

Evaluation of efficacy of syrup «Herbion ivy extract» depending on the timing of its appointment to children with acute bronchitis 

Kolesnyk Pavlo, Petrishchak Vlasta, Tsyapets Sergey

Department of Therapy and Family Medicine, Education and Research Training Center of family medicine and first aid, Faculty of Postgraduate Education, Medical Faculty of Uzhgorod National University, Uzhgorod.Published: Sovremennaya pediatriya. — 2015. — № 8 (72). — Р. 67–73. 

Despite sufficient experimental base on the use of ivy extracts to treat acute inflammatory diseases of the lower airways accompanied by cough, understudied question remains as to the time beginning mucolytic therapy in patients with acute bronchitis and bronchitis symptoms impact on health and quality the lives of children for the disease. We have selected 72 children aged 2–10 years who had symptoms of acute bronchitis and divided them into 2 groups. First group included children who received monotherapy with the extract of ivy in age doses and acetaminophen in case of hyperthermia on the first day of illness; the second group consisted of children, who were sick for 4–5 days, and turned with the deterioration. Purpose the ivy extract from the firs day of illnes to children with acute bronchitis, possible will achieve an early dry heavy coughing transfering to less intensive and wet in 5 days and make shorter the duration of illness into 10–12 days; it also reduced the duration of hyperthermia and have positive effect to the overall health of patients and their daily affairs.

Key words: bronchitis, pathogenetic therapy, extract of ivy, children.

REFERENCES

1. Greunke C, Hage-Hulsmann A, Sorkalla T et al. 2015. A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther. 31: 92—8.

2. Gepdiremen A, Mshvildadze V, Suleyman H, Elias R. 2005. Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine. 12 (6—7): 440—4.

3. Gillissen A, Gessner C, Hammerschmidt S et al. 2006. Acute bronchitis: when are antibiotics, and when is symptomatic treatment indicated? MMW Fortschr Med. 148 (1—2): 26—8.

4. Gulcin I, Mshvildadze V, Gepdiremen A, Elias R. 2004. Antioxidant activity of saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F. Planta Med. 70(6): 561—3. http://dx.doi.org/10.1055/s-2004-827158; PMid:15241892

5. Cwientzek U, Ottillinger B, Arenberger P. 2011. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 18(13): 1105—9. http://dx.doi.org/10.1016/j.phymed.2011.06.014; PMid:21802921

6. Yu M, Shin YJ, Kim N et al. 2015. Determination of saponins and flavonoids in ivy leaf extracts using HPLC-DAD. See comment in PubMed Commons below. J Chromatogr Sci. 53(4): 478—83. http://dx.doi.org/10.1093/chromsci/bmu068; PMid:24981979

7. Thompson M, Vodicka TA, Blair PS et al. 2013. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 11; 347: 7027.

8. Matthys H, Eisebitt R, Seith B, Heger M. 2003. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine. 10; Suppl 4: 7—17.

9. Dicpinigaitis PV, Eccles R, Blaiss MS, Wingertzahn MA. 2015, Jun 15. Impact of Cough and Common Cold on Productivity, Absenteeism, and Daily Life in the United States: ACHOO Survey. Curr Med Res Opin: 1—22.

10. Marquardt P, Kraft K, Nieber K. 2014.Clinical studies on herbal remedies in children: A systematic literature analysis. Planta medica.

11. Stauss-Grabo M, Atiye S, Warnke A et al. 2011. Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan^®Cough Tablets) in the treatment of colds accompanied by coughing. Phytomedicine. 18(6): 433—6. http://dx.doi.org/10.1016/j.phymed.2010.11.009; PMid:21211950

12. Schroeck JL, Ruh CA, Sellick JAJr et al. 2015, Apr 13. Outpatient treatment for upper respiratory tract infections: an evaluation of factors associated with antibiotic misuse. Antimicrob Agents Chemother: AAC.00652—15.

13. Smith SM, Schroeder K, Fahey T. 2014, Nov. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 24.

14. Humer M, Scheller G, Kapellen T et al. 2010. Use of herbal medicine in German children – prevalence, indications and motivation. Dtsch Med Wochenschr. 135(19): 959—64.

15. Wark P. 2011, Jun 20. Bronchitis (acute). BMJ Clin Evid.

16. Wurzel DF, Marchant JM, Clark JE et al. 2014. Wet cough in children: infective and inflammatory characteristics in broncho-alveolar lavage fluid. Pediatr Pulmonol. 49(6): 561—8. http://dx.doi.org/10.1002/ppul.22792; PMid:23788413

17. Zeil S, Schwanebeck U, Vogelberg C. 2014. Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma. Phytomedicine. 21(10): 1216—20. http://dx.doi.org/10.1016/j.phymed.2014.05.006; PMid:24916707